title: Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.
abstract: To gain insight into the function of peroxisome proliferator-activated receptor (PPAR) isoforms in rodents, we disrupted the ligand-binding domain of the alpha isoform of mouse PPAR (mPPAR alpha) by homologous recombination. Mice homozygous for the mutation lack expression of mPPAR alpha protein and yet are viable and fertile and exhibit no detectable gross phenotypic defects. Remarkably, these animals do not display the peroxisome proliferator pleiotropic response when challenged with the classical peroxisome proliferators, clofibrate and Wy-14,643. Following exposure to these chemicals, hepatomegaly, peroxisome proliferation, and transcriptional-activation of target genes were not observed. These results clearly demonstrate that mPPAR alpha is the major isoform required for mediating the pleiotropic response resulting from the actions of peroxisome proliferators. mPPAR alpha-deficient animals should prove useful to further investigate the role of this receptor in hepatocarcinogenesis, fatty acid metabolism, and cell cycle regulation.
authors.affiliation: Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
authors.forename: S S
authors.initials: SS
authors.lastname: Lee
authors.forename: T
authors.initials: T
authors.lastname: Pineau
authors.forename: J
authors.initials: J
authors.lastname: Drago
authors.forename: E J
authors.initials: EJ
authors.lastname: Lee
authors.forename: J W
authors.initials: JW
authors.lastname: Owens
authors.forename: D L
authors.initials: DL
authors.lastname: Kroetz
authors.forename: P M
authors.initials: PM
authors.lastname: Fernandez-Salguero
authors.forename: H
authors.initials: H
authors.lastname: Westphal
authors.forename: F J
authors.initials: FJ
authors.lastname: Gonzalez
mesh_terms: D000818:Animals; D001483:Base Sequence; D002994:Clofibrate / Q000494:pharmacology; D018076:DNA, Complementary; D008099:Liver / Q000502:physiology / Q000648:ultrastructure; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008830:Microbodies / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D008854:Microscopy, Electron; D008969:Molecular Sequence Data; D011743:Pyrimidines / Q000494:pharmacology; D012313:RNA / Q000032:analysis; D018160:Receptors, Cytoplasmic and Nuclear / Q000172:deficiency* / Q000235:genetics; D014157:Transcription Factors / Q000172:deficiency* / Q000235:genetics
chemical_list: D018076:DNA, Complementary; D011743:Pyrimidines; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D012313:RNA; C006253:pirinixic acid; D002994:Clofibrate